The one-direction sensitivity analysis indicated that the ICER was highly influenced by the cost of SGLT2 inhibitors, the cost of hospitalization for heart failure, the cost of standard therapy, and the baseline risks of all-cause death and hospitalization for heart failure (Figure 2). This evidence concerns the gene SLC5A2 and heart failure.